Drug treatment of schizophrenia.
This comprehensive article discusses the great number of antipsychotic drugs available for the treatment of schizophrenia in terms of their pharmacologic and biochemical actions, metabolism and kinetics, and clinical use. New approaches to drug treatment are covered and side effects and complications, interactions, and toxicity are detailed throughout.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002746:Chlorpromazine / Q000378:metabolism; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D007700:Kinetics; D008094:Lithium / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy*; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use; D005879:Tourette Syndrome / Q000188:drug therapy
D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D013973:Thyrotropin-Releasing Hormone; D008094:Lithium; D002746:Chlorpromazine